M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?

Detalles Bibliográficos
Autores principales: Ahluwalia, V., Iyer, V., Joshi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566851/
http://dx.doi.org/10.1016/j.anai.2021.08.332
_version_ 1784594105696780288
author Ahluwalia, V.
Iyer, V.
Joshi, A.
author_facet Ahluwalia, V.
Iyer, V.
Joshi, A.
author_sort Ahluwalia, V.
collection PubMed
description
format Online
Article
Text
id pubmed-8566851
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85668512021-11-04 M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION? Ahluwalia, V. Iyer, V. Joshi, A. Ann Allergy Asthma Immunol Article Published by Elsevier Inc. 2021-11 2021-11-04 /pmc/articles/PMC8566851/ http://dx.doi.org/10.1016/j.anai.2021.08.332 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ahluwalia, V.
Iyer, V.
Joshi, A.
M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
title M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
title_full M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
title_fullStr M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
title_full_unstemmed M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
title_short M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION?
title_sort m191 immune assessment in post-acute sequala of sars-cov2 infection (pasc): evidence of persistent immune activation?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566851/
http://dx.doi.org/10.1016/j.anai.2021.08.332
work_keys_str_mv AT ahluwaliav m191immuneassessmentinpostacutesequalaofsarscov2infectionpascevidenceofpersistentimmuneactivation
AT iyerv m191immuneassessmentinpostacutesequalaofsarscov2infectionpascevidenceofpersistentimmuneactivation
AT joshia m191immuneassessmentinpostacutesequalaofsarscov2infectionpascevidenceofpersistentimmuneactivation

Ejemplares similares